The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A randomized, phase III trial comparing BuCy and BuFlu as a myeloablative conditioning regimen.
S. Kim
No relevant relationships to disclose
J. Lee
No relevant relationships to disclose
Y. Joo
No relevant relationships to disclose
H. Kim
No relevant relationships to disclose
H. Ryoo
No relevant relationships to disclose
M. K. Kim
No relevant relationships to disclose
G. Lee
No relevant relationships to disclose
J. Lee
No relevant relationships to disclose
W. Lee
No relevant relationships to disclose
J. H. Park
No relevant relationships to disclose
S. H. Bae
No relevant relationships to disclose
M. S. Hyun
No relevant relationships to disclose
D. Kim
No relevant relationships to disclose
Y. J. Min
No relevant relationships to disclose